ACTRN12622000404729
Recruiting
未知
Prospective trial investigating the safety of peripheral vasopressors in pre-hospital and retrieval medicine
Robert Ley Greaves0 sites400 target enrollmentMarch 9, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Robert Ley Greaves
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •any patient being transferred by Lifeflight retrieval medicne receiving peripheral vasopressors, including inter facility and pre hospital work.
Exclusion Criteria
- •\-Complication of peripheral vasopressor prior to transfer
- •\-Patient not transported by LRM ie clinical improvement or decline precluding transport
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Confirmatory clinical trial about safeness of perioperative blood glucose management using artificial pancreas in division of hepato-pancreato-biliary surgery1) Hepatectomy above 2 sectors 2) Pansreatoduodenectomy 3) Liver transplantationJPRN-UMIN000016451Department of Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University45
Completed
Not Applicable
Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitisAcute cholecystitisJPRN-UMIN000002052Chiba University Graduate School of Medicine78
Active, not recruiting
Not Applicable
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusEUCTR2012-003566-41-BEovo Nordisk A/S346
Active, not recruiting
Not Applicable
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-003566-41-SIovo Nordisk A/S346
Active, not recruiting
Not Applicable
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusEUCTR2012-003566-41-HRovo Nordisk A/S346